 Crinetics Pharmaceuticals Inc NASDAQ:CRNX major shareholder Vivo Capital Viii, Llc sold 215,810 shares of the businesss stock in a transaction that occurred on Wednesday, April 15th. The stock was sold at an average price of 15.50, for a total transaction of 3,345,055.00. The sale was disclosed in a legal filing with the Securities Exchange ... 